Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: An early sign of cardiac involvement

Journal of Nuclear Medicine

Volumn 42, Issue 2, 2001, Pages 183-188

  Nakajima, K ^a   Taki, J ^a   Kawano, M ^a   Higuchi, T ^a   Sato, S ^a   Nishijima, C ^a   Takehara, K ^a   Tonami, N ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

99mTc methoxyisobutylisonitrile; Diastolic function; Gated SPECT; Skin score; Systemic sclerosis

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIASTOLE; FEMALE; FOURIER ANALYSIS; GATED IMAGING; HEART CYCLE; HEART DISEASE; HEART EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; IMAGING SYSTEM; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC SCLEROSIS;

CORONARY CIRCULATION; DIASTOLE; FEMALE; HEART DISEASES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; RADIOPHARMACEUTICALS; SCLERODERMA, SYSTEMIC; STROKE VOLUME; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035122465     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pathologic observation in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls
2. Myocardial lesions of progressive systemic sclerosis: A cause of cardiac dysfunction
3. The cardiac conduction system in progressive systemic sclerosis: Clinical and pathologic features of 35 patients
4. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma
5. Survival with systemic sclerosis (scleroderma): A life-table analysis of clinical and demographic factors in 309 patients
6. Clinical aspects of localized and systemic sclerosis
7. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis
8. Cold-induced reversible myocardial ischaemia in systemic sclerosis
9. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis
10. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis
11. Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease
12. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
13. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography
14. Diastolic function and myocardial structure in patients with myocardial hypertrophy: Special reference to normalized viscoelastic data
15. Left ventricular diastolic performance at rest and during exercise in patients with coronary artery disease: Assessment with first-pass radionuclide angiography
16. Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography
17. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy
18. Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension
19. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
20. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
21. Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies
22. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis
23. Split renal function testing using Tc-99m DTPA: A rapid technique for determining differential glomerular filtration
24. Gated SPET quantification of small hearts: Mathematical simulation and clinical application
25. Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis
26. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA tomoisomerase I antibody
27. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies
28. Scleroderma heart disease: An unusual cause of positive antimyosin cardiac imaging
29. 123I-MIBG neurotransmitter scintigraphy
30. Left ventricular diastolic dysfunction in systemic sclerosis: Assessment by radionuclide angiography
31. Diastolic properties of the left ventricle
32. Left ventricular compliance: Mechanism and clinical implications
33. Factors which affect the diastolic pressure-volume curve
34. Diastolic and systolic parameters obtained by myocardial ECG-gated perfusion study